Baker Gordon Syndrome Natural History Study
Recruiting · NCT06399952 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Missouri-Columbia
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.
Who can take part
Age range
0 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Genetically confirmed diagnosis of Baker Gordon syndrome.
- 0-99 years
- Ability to send medical records and diagnostic test results.
- Ability to complete tests and questionnaires.
Exclusion criteria
- The presence of another condition or co-morbidity unrelated to Baker Gordon syndrome, that affects neurodevelopment.
- In this study, the primary caregivers/LAR for each participant diagnosed Baker Gordon Syndrome will be also considered participants.
- Caregivers/LAR will have to meet the following inclusion criteria:
- \>18 years.
- Legal caregiver of the patient diagnosed with a Baker Gordon Syndrome.
- Willingness to follow study procedures, as assessed by the research team.
- Willingness to sign the consent form.
- Ability to understand all the information regarding the study, as assessed by the research team.
- Caregivers/LAR Exclusion Criteria:
- Less than 18 years old.
Where it is running
1 location listed across 1 US state.
- University of Missouri Columbia - Columbia, Missouri, United States